Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Biomarkers, fatigue, and cognitive impairment in recently diagnosed multiple sclerosis treated with Rebif 44
2007-004937-41Phase 4Active
- Sponsor
- CHRU Nancy
- Start
- Dec 2007
- Modality
- Cytokines & Interferons → Recombinant Proteins and Enzymes
- Countries
- 1
01
Overview
Phase 4, open-label, single-arm trial of interferon beta-1a in multiple sclerosis (MS), sponsored by CHRU Nancy. Started Dec 2007; status: active.
02
Drugs
interferon beta-1a
03
Conditions
multiple sclerosis (MS)
Beyond the preview
Go deeper on 2007-004937-41.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2007-004937-41.